HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A double-blind controlled evaluation of Actifed and its individual constituents in allergic rhinitis.

Abstract
Pseudoephedrine and triprolidine, administered every 6 hours as a combination, made separate and distinct contributions to the treatment of allergic rhinitis. Furthermore, the combination was perceived by the patients as being clinically superior to either of its components or placebo.
AuthorsJ T Connell, B O Williams, S Allen, A Cato, J G Perkins
JournalThe Journal of international medical research (J Int Med Res) Vol. 10 Issue 5 Pg. 341-7 ( 1982) ISSN: 0300-0605 [Print] England
PMID6128282 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Drug Combinations
  • Histamine H1 Antagonists
  • Placebos
  • Pyridines
  • pseudoephedrine, triprolidine drug combination
  • Triprolidine
  • Pseudoephedrine
  • Ephedrine
Topics
  • Clinical Trials as Topic
  • Double-Blind Method
  • Drug Combinations (therapeutic use)
  • Ephedrine (therapeutic use)
  • Histamine H1 Antagonists (therapeutic use)
  • Humans
  • Placebos
  • Pseudoephedrine
  • Pyridines (therapeutic use)
  • Rhinitis, Allergic, Seasonal (drug therapy)
  • Triprolidine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: